Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.65), $0.08 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $1.46 million versus the consensus estimate of $3.75 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.